Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
1501
-
1502
-
1503“…This research explored whether hepatitis C virus (HCV) infection leads to the development of intracerebral hemorrhage (ICH). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1504por Huang, Wen-Lin, Tsai, Ming-Ju, Hsu, Kai-Ti, Wang, Jyun-Rong, Chen, Yi-Hsiung, Ho, Shinn-Ying“…BACKGROUND: High genetic heterogeneity in the hepatitis C virus (HCV) is the major challenge of the development of an effective vaccine. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1505
-
1506“…The anti-Rods and Rings autoantibody recently described in clinical populations is thought to occur in the setting of hepatitis C treatment, specifically in the context of cytidine triphosphate (CTP) and guanosine triphosphate (GTP) synthetic pathway inhibitors, and is important in its potential impact on response to therapy. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1507“…Hepatitis C virus (HCV) infects an estimated 130-150 million people worldwide, becoming the major cause of chronic liver disease, cirrhosis, hepatocellular carcinoma, and liver transplantation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1508por El-shishtawy, Samya, Sherif, Nevine, Abdallh, Emad, Kamel, Laila, Shemis, Mohamed, Saleem, Abdel Aziz Ali, Abdalla, Haitham, el Din, Hesham Gamal“…INTRODUCTION: A new form of hepatitis C virus infection, known as occult hepatitis C virus (HCV) infection, is characterized by the presence of HCV_RNA in the liver or peripheral blood mononuclear cells (PBMCs). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1509por Feng, Joy Y., Xu, Yili, Barauskas, Ona, Perry, Jason K., Ahmadyar, Shekeba, Stepan, George, Yu, Helen, Babusis, Darius, Park, Yeojin, McCutcheon, Krista, Perron, Michel, Schultz, Brian E., Sakowicz, Roman, Ray, Adrian S.“…Toxicity has emerged during the clinical development of many but not all nucleotide inhibitors (NI) of hepatitis C virus (HCV). To better understand the mechanism for adverse events, clinically relevant HCV NI were characterized in biochemical and cellular assays, including assays of decreased viability in multiple cell lines and primary cells, interaction with human DNA and RNA polymerases, and inhibition of mitochondrial protein synthesis and respiration. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1510“…AAC caused by viral hepatitis, with hepatitis A, B and EBV infections are rare, but well documented in the literature. Hepatitis C virus has not been reported as cause of AAC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1511por Perumpail, Ryan B., Wong, Robert J., Liu, Andy, Jayasekera, Channa R., Dieterich, Douglas T., Younossi, Zobair M., Ahmed, AijazEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1512por Saab, Sammy, Rheem, Justin, Jimenez, Melissa, Bau, Sherona, Choi, Gina, Durazo, Francisco, El Kabany, Mohammed, Han, Steven, Farid, Alexander, Jamal, Naadir, Grotts, Jonathan, Elashoff, David, Busuttil, Ronald W.“…Background and Aims: All-oral interferon-free antivirals are highly effective in treating recurrent hepatitis C (HCV) infection in liver transplant (LT) recipients. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1513
-
1514“…Epidemiological studies have validated the association between hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1515por Hopcraft, Sharon E., Azarm, Kristopher D., Israelow, Benjamin, Lévêque, Nicolas, Schwarz, Megan C., Hsu, Tien-Huei, Chambers, Matthew T., Sourisseau, Marion, Semler, Bert L., Evans, Matthew J.“…Hepatitis C virus (HCV) replication requires binding of the liver-specific microRNA (miRNA) miR-122 to two sites in the HCV 5′ untranslated region (UTR). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1516por Turner, Samuel S., Gianella, Sara, Yip, Marcus J-S., van Seggelen, Wouter O., Gillies, Robert D., Foster, Andrew L., Barbati, Zachary R., Smith, Davey M., Fierer, Daniel S.“…Hepatitis C virus was shed in 16 (27%) of semen specimens from 11 (33%) of the men. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1517“…AIM: To evaluate immunological indices in HIV-infected patients with chronic hepatitis C (CHC) who are injecting drug users. MATERIALS AND METHODS: The study examined 38 patients coinfected with HIV and CHC who were injecting drug users and 36 patients with HIV/CHC who were not injecting drug users. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1518por Hesamizadeh, Khashayar, Sharafi, Heidar, Rezaee-Zavareh, Mohammad Saeid, Behnava, Bita, Alavian, Seyed Moayed“…CONTEXT: After the introduction of safe and highly effective hepatitis C virus (HCV) treatments, eradication of HCV in the next 20 years is the ultimate goal. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1519por Poortahmasebi, Vahdat, Emami Aleagha, Mohammad Sajad, Amiri, Mehdi, Qorbani, Mostafa, Farahmand, Mohammad, Asayesh, Hamid, Alavian, Seyed Moayed“…Background: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC). Many studies indicate a relationship between steatosis and fibrosis progression. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1520por Saab, Sammy, Jimenez, Melissa, Fong, Tiffany, Wu, Crystal, Bau, Sherona, Jamal, Zoha, Grotts, Jonathan, Elashoff, David“…Background: Hepatitis C (HCV) direct acting antiviral agents (DAAs) are safe, effective, and tolerable. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto